Icon

DEPO-MEDROL (nda011757)- (20MG/ML,40MG/ML,80MG/ML)

METHYLPREDNISOLONE ACETATE PFIZER
20MG/ML,40MG/ML,80MG/ML
No No
Expired Expired
None None
None No
DEPO-MEDROL is indicated for intralesional use in alopecia areata, discoid lupus erythematosus, keloids, localized hypertrophic, infiltrated, inflammatory lesions of granuloma annulare, lichen planus, lichen simplex chronicus (neurodermatitis), and psoriatic plaques, necrobiosis lipoidica diabeticorum. DEPO-MEDROL also may be useful in cystic tumors of an aponeurosis or tendon (ganglia). DEPO-MEDROL is indicated as adjunctive therapy for short-term administration (to tide the patient over an acute episode or exacerbation) in acute gouty arthritis, acute and subacute bursitis, acute nonspecific tenosynovitis, epicondylitis, rheumatoid arthritis, synovitis of osteoarthritis.
10 0 7
Total Other Developers 19
Drugs with Suitability No
20MG/ML ** ** - - -
40MG/ML ** ** - - 5
80MG/ML ** ** - - 4
NDA Sales Available Total Generic Sales Available
Yes 5
ANDA No Generic Co Manufacturer Name Operations Manufacturer Address Country
****** ****** ****** *************** ******* ******* *********** **** **. **, ******* ******* ******** **** *******-***** *.*. **. **, ***.: ******, ***. ******, *********, ** ******, ***** (***) ***
****** ******** ****** *** *********** ******** ********** ************ ********** *** *********** *** ******* **, ****, ** *****, ***** (***) ***
****** ****** ****** *************** ******* ******* *********** **** **. **, ******* ******* ******** **** *******-***** *.*. **. **, ***.: ******, ***. ******, *********, ** ******, ***** (***) ***

Download GenUS Drug Report


Download GenUS Detailed Report


To get detailed report Contact Us

GenUs Advanced Search




Expired
to
Expired
to


Brand Name Generic Name Strength Dosage Route of Administration Innovator ParaIV

Please contact contact@researchdelta.com to get more details.